Literature DB >> 3171242

Coronary vasomotor and clinical effects of nifedipine in effort, mixed and Prinzmental angina.

A Polese1, N De Cesare, A Bartorelli, F Fabbiocchi, A Loaldi, P Montorsi, M D Guazzi.   

Abstract

Changes induced by nifedipine (10 mg s.l.) in the residual lumen diameter of significant (greater than 50%) coronary lesions were assessed angiographically in 69 patients with effort angina (Group 1), in 22 patients with mixed angina (Group 2), and in 14 patients with Prinzmental angina (Group 3). These changes were related to the clinical response to treatment with the same drug (diary records, exercise testing, Holter monitoring). In Groups 1 and 2 segments of stenotic vessels showed either increase, decrease or no change in diameter with the calcium antagonist; in Group 3 the majority of the vessels showed compliant portions which invariably responded with dilatation. Nifedipine failed to improve cases with exertional (21% unchanged, 19% worsened) and mixed (41% exacerbated) forms; all patients with the Prinzmental form had relief of the anginal episodes. In Group 1, the response to exercise tests were dissociated from the acute vasomotor pattern and the pressure-rate product failed to explain the clinical results. Fifty-two percent of the patients in Group 2 showed significant acute widening of critical stenoses as well as obvious improvement; patients in this group who did worse with treatment had reacted to nifedipine with narrowing of their critical stenoses. These data suggest that: the response to nifedipine of classic effort angina is probably the net result of an interaction of changes in myocardial oxygen consumption and supply; coronary vasomotion has a role in mixed angina and influences of nifedipine may be either favorable or unfavorable; stenotic lesions in the Prinzmental form are quite sensitive to the relaxant action of calcium blockade and this probably represents a background to the highly positive clinical response to treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171242     DOI: 10.1007/bf01814882

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  28 in total

1.  Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise.

Authors:  M B Higginbotham; K G Morris; R E Coleman; F R Cobb
Journal:  Am J Cardiol       Date:  1986-05-01       Impact factor: 2.778

2.  Analysis of coronary responses to nifedipine alone and in combination with intracoronary nitroglycerin in patients with coronary artery disease.

Authors:  R L Feldman; J A Hill; J B Conti; C R Conti; C J Pepine
Journal:  Am Heart J       Date:  1983-04       Impact factor: 4.749

3.  Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.

Authors:  P H Stone; J E Muller; Z G Turi; E Geltman; A S Jaffe; E Braunwald
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

4.  Paradoxical angina after nifedipine: angiographic documentation.

Authors:  P Schanzenbächer; P Deeg; G Liebau; K Kochsiek
Journal:  Am J Cardiol       Date:  1984-01-15       Impact factor: 2.778

5.  Antianginal effect of nifedipine after intracoronary and intravenous administration judged by reduction of ischemic ST-segment depression in exercise tests.

Authors:  W Schulz; M Kaltenbach
Journal:  Cardiology       Date:  1981       Impact factor: 1.869

6.  Treatment of spasm of the coronary artery with nifedipine.

Authors:  M E Bertrand; J M Lablanche; P Y Tilmant
Journal:  Eur Heart J       Date:  1980-12       Impact factor: 29.983

7.  Pathogenetic mechanisms of angina pectoris: expanding views.

Authors:  A Maseri
Journal:  Br Heart J       Date:  1980-06

Review 8.  Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.

Authors:  P D Henry
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

9.  Effects of nifedipine on myocardial perfusion and ischemic injury in dogs.

Authors:  P D Henry; R Shuchleib; L J Borda; R Roberts; J R Williamson; B E Sobel
Journal:  Circ Res       Date:  1978-09       Impact factor: 17.367

10.  Influence of intracoronary nifedipine on left ventricular function, coronary vasomotility, and myocardial oxygen consumption.

Authors:  P W Serruys; T E Hooghoudt; J H Reiber; C Slager; R W Brower; P G Hugenholtz
Journal:  Br Heart J       Date:  1983-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.